Eishingdrelo Haifeng, Sun Wei, Li Hua, Wang Li, Eishingdrelo Alex, Dai Sheng, McKew John C, Zheng Wei
BioInvenu Corp., East Hanover, NJ, USA
National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
J Biomol Screen. 2015 Mar;20(3):341-9. doi: 10.1177/1087057114557233. Epub 2014 Oct 31.
β-Arrestin, a signal adaptor protein, mediates intracellular signal transductions through protein-protein interactions by bringing two or more proteins in proximity. Extracellular signal-regulated kinase (ERK), a protein kinase in the family of mitogen-activated protein kinases (MAPKs), is involved in various receptor signal pathways. Interaction of ERK with β-arrestin or formation of ERK/β-arrestin signal complex occurs in response to activation of a variety of cell surface receptors. The ERK/β-arrestin signal complex may be a common transducer to converge a variety of extracellular stimuli to similar downstream intracellular signaling pathways. By using a cell-based protein-protein interaction LinkLight assay technology, we demonstrate a direct interaction between ERK and β-arrestin in response to extracellular stimuli, which can be sensitively and quantitatively monitored. Activations of G protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), and cytokine receptors promote formation of the ERK/β-arrestin signal complex. Our data indicate that the ERK/β-arrestin signal complex is a common transducer that participates in a variety of receptor signaling pathways. Furthermore, we demonstrate that receptor antagonists or kinase inhibitors can block the agonist-induced ERK and β-arrestin interaction. Thus, the ERK/β-arrestin interaction assay is useful for screening of new receptor modulators.
β-抑制蛋白是一种信号衔接蛋白,通过使两种或更多种蛋白质相互靠近,介导细胞内信号转导。细胞外信号调节激酶(ERK)是丝裂原活化蛋白激酶(MAPK)家族中的一种蛋白激酶,参与多种受体信号通路。ERK与β-抑制蛋白的相互作用或ERK/β-抑制蛋白信号复合物的形成是在多种细胞表面受体激活后发生的。ERK/β-抑制蛋白信号复合物可能是一种常见的转导器,将多种细胞外刺激汇聚到相似的下游细胞内信号通路。通过使用基于细胞的蛋白质-蛋白质相互作用LinkLight检测技术,我们证明了在细胞外刺激下ERK与β-抑制蛋白之间存在直接相互作用,这种相互作用可以被灵敏且定量地监测。G蛋白偶联受体(GPCR)、受体酪氨酸激酶(RTK)和细胞因子受体的激活促进了ERK/β-抑制蛋白信号复合物的形成。我们的数据表明,ERK/β-抑制蛋白信号复合物是一种参与多种受体信号通路的常见转导器。此外,我们证明受体拮抗剂或激酶抑制剂可以阻断激动剂诱导的ERK与β-抑制蛋白的相互作用。因此,ERK/β-抑制蛋白相互作用检测对于筛选新的受体调节剂很有用。